Literature DB >> 26669764

Liver cancer: TGF-β and cholangiocarcinoma.

Gillian Patman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26669764     DOI： 10.1038/nrgastro.2015.218

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.

Authors:  Xueru Mu; Jean-Philippe Pradere; Silvia Affò; Dianne H Dapito; Richard Friedman; Jay H Lefkovitch; Robert F Schwabe
Journal:  Gastroenterology       Date:  2015-11-26       Impact factor: 22.682
  1 in total
  1 in total

1.  Transforming growth factor-β and peripheral regulatory cells are negatively correlated with the overall survival of hepatocellular carcinoma.

Authors:  Yang An; Song Gao; Wen-Chao Zhao; Bao-An Qiu; Nian-Xin Xia; Peng-Jun Zhang; Zhen-Ping Fan
Journal:  World J Gastroenterol       Date:  2018-07-07       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.